NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
0.580
-0.010 (-1.68%)
At close: Dec 20, 2024, 4:00 PM
0.550
-0.030 (-5.21%)
After-hours: Dec 20, 2024, 7:59 PM EST
NanoVibronix Employees
As of December 31, 2023, NanoVibronix had 16 total employees, including 10 full-time and 6 part-time employees. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
$205,688
Profits / Employee
-$192,938
Market Cap
2.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
cbdMD | 52 |
Aptevo Therapeutics | 40 |
Biodexa Pharmaceuticals | 21 |
Cyclacel Pharmaceuticals | 12 |
Bluejay Diagnostics | 10 |
TransCode Therapeutics | 10 |
Palisade Bio | 9 |
Dermata Therapeutics | 8 |
NAOV News
- 10 days ago - NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement - Business Wire
- 5 weeks ago - NanoVibronix Provides Business Update - Business Wire
- 2 months ago - NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - Business Wire
- 3 months ago - NanoVibronix Signs Letter of Intent with Potential New Distributor - Business Wire
- 4 months ago - NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - Business Wire
- 7 months ago - NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan - Business Wire
- 7 months ago - NanoVibronix Issues Letter to Stockholders - Business Wire
- 7 months ago - NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield - Business Wire